Fluctuation of lipoprotein metabolism linked with bile acid-activated liver nuclear receptors in Alagille syndrome.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Atherosclerosis

• Publication date

  2008-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.atherosclerosis.2008.02.020PMID 18430427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of LXRs prevents bile acid toxicity and cholestasis in female mice

  2007cited by this paper
• Liver X receptor inhibits the synthesis and secretion of apolipoprotein A1 by human liver-derived cells.

  2006cited by this paper
• An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.

  2006cited by this paper
• Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters.

  2006cited by this paper
• Cholesteryl ester transfer protein (CETP) expression enhances HDL cholesteryl ester liver delivery, which is independent of scavenger receptor BI, LDL receptor related protein and possibly LDL receptor.

  2006cited by this paper
• Transcriptional regulatory networks in lipid metabolism control ABCA1 expression.

  2005cited by this paper
• Bile acids reduce SR-BI expression in hepatocytes by a pathway involving FXR/RXR, SHP, and LRH-1.

  2005cited by this paper
• SR-BI- and ABCA1-mediated cholesterol efflux to serum from patients with Alagille syndrome Published, JLR Papers in Press, June 21, 2004. DOI 10.1194/jlr.M400133-JLR200

  2004cited by this paper
• Raising HDL cholesterol without inducing hepatic steatosis and hypertriglyceridemia by a selective LXR modulator Published, JLR Papers in Press, June 1, 2004. DOI 10.1194/jlr.M300450-JLR200

  2004cited by this paper
• The role of Notch receptor expression in bile duct development and disease

  2004influential reference
• Vascular Anomalies in Alagille Syndrome: A Significant Cause of Morbidity and Mortality

  2004influential reference
• Farnesoid X Receptor Activates Transcription of the Phospholipid Pump MDR3*

  2003cited by this paper
• Regulation of cholesterol-7α-hydroxylase: BAREly missing a SHP

  2002cited by this paper
• Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.

  2002cited by this paper
• Regulation of cholesterol-7alpha-hydroxylase: BAREly missing a SHP.

  2002cited by this paper
• Nuclear receptor-mediated repression of human cholesterol 7alpha-hydroxylase gene transcription by bile acids.

  2001cited by this paper
• Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element.

  2000cited by this paper
• Features of alagille syndrome in 92 patients: Frequency and relation to prognosis

  1999influential reference
• Cholesterol efflux from Fu5AH cells to the serum of patients with Alagille syndrome. Importance of the hdl-phospholipids/free cholesterol ratio and of the hdl size distribution.

  1999cited by this paper
• UvA-DARE ( Digital Academic Repository ) Class III P-glycoproteins mediate the formation of lipoprotein X in the mouse

  1998cited by this paper
• Cholesteryl ester transfer activity in liver disease and cholestasis, and its relation with fatty acid composition of lipoprotein lipids.

  1996cited by this paper
• Abnormal lipoprotein pattern in patients with Alagille syndrome depends on Icterus severity.

  1996cited by this paper
• Role of lecithin:cholesterol acyltransferase and apolipoprotein A-I in cholesterol esterification in lipoprotein-X in vitro.

  1995cited by this paper
• Lipoprotein pattern and plasma lecithin cholesterol acyl transferase activity in children with Alagille syndrome.

  1995cited by this paper
• Decrease of hepatic triglyceride lipase levels and increase of cholesteryl ester transfer protein levels in patients with primary biliary cirrhosis: Relationship to abnormalities in high‐density lipoprotein

  1993cited by this paper
• Spurious elevation of serum high-density lipoprotein cholesterol in patients with cholestatic liver diseases.

  1991cited by this paper
• [Determination of the serum concentration of lipoproptein x (author's transl)].

  1981cited by this paper
• Biosynthesis of 24,25-epoxycholesterol from squalene 2,3;22,23-dioxide.

  1981cited by this paper
• Analyse de livres

  1980cited by this paper
• Formation of lipoprotein-X. Its relationship to bile compounds.

  1976cited by this paper
• Chapter 7 – LIVER DISEASE IN INFANCY AND CHILDHOOD

  1969cited by this paper

• A two-step homogeneous assay for apolipoprotein E-containing high-density lipoprotein-cholesterol

  2018cites this paper
• New JAG1 Mutation Causing Alagille Syndrome Presenting With Severe Hypercholesterolemia: Case Report With Emphasis on Genetics and Lipid Abnormalities

  2016cites this paper
• The potential of cholesteryl ester transfer protein as a therapeutic target

  2016cites this paper
• Negative feedback loop of cholesterol regulation is impaired in the livers of patients with Alagille syndrome.

  2015cites this paper
• Alagille综合征的临床特征 Clinical Features of Alagille Syndrome

  2014cites this paper
• Validation of homogeneous assays for HDL-cholesterol using fresh samples from healthy and diseased subjects.

  2014cites this paper
• Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice[S]

  2013cites this paper
• A phenolic antioxidant from the Pacific oyster (Crassostrea gigas) inhibits oxidation of cultured human hepatocytes mediated by diphenyl-1-pyrenylphosphine.

  2012cites this paper
• COLESTASIS: ENFOQUE ACTUAL P J M.D.

  2010cites this paper
• Current world literature.

  2009cites this paper